Literature DB >> 35962105

A commentary on Temporomandibular disorders: priorities for research and care - bridging from the US to the UK.

Justin Durham1, Charles Greene2, Richard Ohrbach3.   

Abstract

In January 2019, the United States National Academy of Medicine initiated a comprehensive study of the status of current knowledge and clinical practices associated with temporomandibular disorders (TMDs). The National Academy of Sciences, which includes the National Academy of Medicine, was chartered by the US Government in the late 1800s as a non-profit institution working outside of government in order to provide unbiased, objective opinions on matters including healthcare. In this brief paper, we will discuss the open access 2020 report Temporomandibular disorders: priorities for research and care, available online. While the main focus of this report was the situation of TMDs in the US, the evidence base, authorship, expertise and literature scope was international and the findings therefore are at least in part generalisable to and important for the UK.The authors of this commentary were directly involved in the National Academy process, with RO a panel member, JD a consultant and CG one of 15 reviewers of the draft report. There was a wide variety of clinical and research fields involved in gathering the evidence and constructing the report. In addition, there was extensive involvement from affected patients with TMDs and their families, which is critical because their perspective is typically omitted in textbooks and professional consensus meetings.
© 2022. The Author(s), under exclusive licence to the British Dental Association.

Entities:  

Mesh:

Year:  2022        PMID: 35962105      PMCID: PMC9372950          DOI: 10.1038/s41415-022-4501-6

Source DB:  PubMed          Journal:  Br Dent J        ISSN: 0007-0610            Impact factor:   2.727


  10 in total

1.  Oral rehabilitation, disability and dentistry.

Authors:  J Durham; R Ohrbach
Journal:  J Oral Rehabil       Date:  2010-04-05       Impact factor: 3.837

Review 2.  Self-management in temporomandibular disorders: a systematic review of behavioural components.

Authors:  W P Story; J Durham; M Al-Baghdadi; J Steele; V Araujo-Soares
Journal:  J Oral Rehabil       Date:  2016-08-04       Impact factor: 3.837

Review 3.  Differential diagnosis of facial pain and guidelines for management.

Authors:  J M Zakrzewska
Journal:  Br J Anaesth       Date:  2013-07       Impact factor: 9.166

4.  Self-management programmes in temporomandibular disorders: results from an international Delphi process.

Authors:  J Durham; M Al-Baghdadi; L Baad-Hansen; M Breckons; J P Goulet; F Lobbezoo; T List; A Michelotti; D R Nixdorf; C C Peck; K Raphael; E Schiffman; J G Steele; W Story; R Ohrbach
Journal:  J Oral Rehabil       Date:  2016-11-01       Impact factor: 3.837

5.  Implementation of biopsychosocial supported self-management for chronic primary oro-facial pain including temporomandibular disorders: A theory, person and evidence-based approach.

Authors:  Vishal R Aggarwal; Jianhua Wu; Frank Fox; Daniel Howdon; Elspeth Guthrie; Alan Mighell
Journal:  J Oral Rehabil       Date:  2021-07-17       Impact factor: 3.837

6.  The effectiveness of self-management interventions in adults with chronic orofacial pain: A systematic review, meta-analysis and meta-regression.

Authors:  Vishal R Aggarwal; Yu Fu; Chris J Main; Jianhua Wu
Journal:  Eur J Pain       Date:  2019-02-07       Impact factor: 3.931

Review 7.  Temporomandibular disorders.

Authors:  Justin Durham; Toby R O Newton-John; Joanna M Zakrzewska
Journal:  BMJ       Date:  2015-03-12

8.  Healthcare Cost and Impact of Persistent Orofacial Pain: The DEEP Study Cohort.

Authors:  J Durham; J Shen; M Breckons; J G Steele; V Araujo-Soares; C Exley; L Vale
Journal:  J Dent Res       Date:  2016-05-06       Impact factor: 6.116

9.  DEEP Study: Indirect and Out-of-pocket Costs of Persistent Orofacial Pain.

Authors:  M Breckons; J Shen; J Bunga; L Vale; J Durham
Journal:  J Dent Res       Date:  2018-07-16       Impact factor: 6.116

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.